Continuing to Suffer from Weak Demand
Harmonicare's H1 results were consistent with the profit warning issued earlier this month: Revenue decreased by 1.7% Y/Y (including Heilongjiang...
624 Views
No News Is, Well, No News
iKang Healthcare Group (ADR) (KANG US) recently reported its Q4FY2016 (March 2017) results. The underlying trends were stable (unit growth strong,...
854 Views
Roundup of the Medical Examination Sector
Shares of IKang Healthcare Group (ADR) (KANG US) have pulled back to around US$14/ADS since our last Insight Drifting Along, But Business Holding...
830 Views
Limbo for IKang Healthcare
iKang Healthcare’s shares have declined by 12% from US$19.57 in June to US$17.27 currently, and now trade at a 15%+ discount to the suggested offer...
403 Views
Guangdong Kanghua IPO Review - Two Average Hospitals Not Deserving of a Premium
 Guangdong Kanghua Healthcare (3689 HK) plans to raise about US$126 - 157m in its IPO through selling 84m primary share. Our fellow insight...
453 Views